AtriCure Publishes Inaugural ESG Report

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today published its inaugural Environmental, Social and Governance (ESG) report highlighting the company’s corporate responsibility and sustainability initiatives. AtriCure’s 2021 ESG Report showcases several of the company’s recent ESG accomplishments, including: Achieving

Leave a Reply

Your email address will not be published. Required fields are marked *